Evidence map›Paper›PMID 26123900›Full record

Trial reportClinical and experimental immunology2015

Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.

A Jamin, L Dehoux, C Dossier, M Fila, N Heming, R C Monteiro, G Deschênes

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Clinical and experimental immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Forging the Future: B Cell Activating Factor's Impact on Nephrotic Syndrome.The Malaysian journal of medical sciences : MJMS · 2024
    Review
  2. Review
  3. Article
  4. Review
  5. Trends in pediatric nephrotic syndrome.World journal of nephrology · 2021
    Review
  6. Article
  7. Genetics of childhood steroid-sensitive nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2017
    Review
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

A JaminINSERM U1149, CNRS ERL8252, Center for Research on Inflammation, Bichat Medical School, Paris, France.
L DehouxINSERM U1149, CNRS ERL8252, Center for Research on Inflammation, Bichat Medical School, Paris, France.
C DossierDHU Fire, Paris, France.
M FilaDHU Fire, Paris, France.
N HemingINSERM U1149, CNRS ERL8252, Center for Research on Inflammation, Bichat Medical School, Paris, France.
R C MonteiroINSERM U1149, CNRS ERL8252, Center for Research on Inflammation, Bichat Medical School, Paris, France.
G DeschênesINSERM U1149, CNRS ERL8252, Center for Research on Inflammation, Bichat Medical School, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRSorbonne Paris Cité · FRCentre de Recherche sur l'Inflammation · FRCentre National de la Recherche Scientifique · FRHôpital Robert-Debré · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of steroids and immunosuppressive treatments in idiopathic nephrotic syndrome (INS) hints at the implication of immune cells in the pathophysiology of the disease. Toll-like receptor (TLR) dysfunctions are involved in many kidney diseases of immune origin, but remain little described in INS. We investigated the expression and function of TLRs in peripheral blood mononuclear cells (PBMC) of INS children, including 28 in relapse, 23 in remission and 40 controls. No child had any sign of infection, but a higher Epstein-Barr virus viral load was measured in the PBMC of relapsing patients. TLR-3 expression was increased in B cells only during INS remission. There was a negative correlation between proteinuria and TLR-3 expression in total and the main subsets of PBMC from INS patients. The expression of TLR-8 was also increased in both CD4(+) T cells and B cells in INS remission. There was a negative correlation between proteinuria and TLR-8 expression in total PBMC, CD4(+) T cells and B cells of INS patients. Nevertheless, TLR-3 and TLR-8 expression was normalized in all PBMC subsets in an additional group of 15 INS patients in remission with B cell repletion after rituximab therapy. Paradoxically, interferon (IFN) regulatory factor 3 transactivation was increased in PBMC of all INS patients. In-vitro secretion of IFN-α and interleukin 6 were increased spontaneously in PBMC of INS remission patients, whereas PBMC from all INS patients displayed an impaired IFN-α secretion after TLR-3 stimulation. Thus, TLR-3 pathway dysfunctions may be closely involved in INS pathogenesis.

Indexed as

AdolescentB-LymphocytesCD4-Positive T-LymphocytesChildChild, PreschoolEpstein-Barr Virus InfectionsFemaleGene Expression RegulationHerpesvirus 4, HumanHumansInfantInterferon-alphaInterleukin-6MaleNephrotic SyndromeRituximabIL6 protein, humanInterferon-alphaInterleukin-6RituximabTLR3 protein, humanTLR8 protein, humanToll-Like Receptor 3Toll-Like Receptor 8blood leucocytescytokinesimmunoglobulinsproteinuriasteroid-sensitive nephrotic syndrome

Identifiers

PMID26123900
PMCPMC4636895
OpenAlexW2125521961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.